|
|
||||||||||
|
J Am Coll Cardiol, 2003; 41:1547-1553, doi:10.1016/S0735-1097(03)00193-1 © 2003 by the American College of Cardiology Foundation |

* Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, USA
Heart Disease Prevention Program, University of California, Irvine, California, USA
Manuscript received July 30, 2002; revised manuscript received November 12, 2002, accepted January 2, 2003.
* Reprint requests and correspondence: Dr. Daniel S. Berman, Department of Imaging, Cedars-Sinai Medical Center, 8700 Beverly Building, Room A041, Los Angeles, California 90048, USA.
bermand{at}cshs.org
OBJECTIVES: We compared the prevalence and extent of coronary artery calcium (CAC) among persons with the metabolic syndrome (MetS), diabetes, and neither condition.
BACKGROUND: The prevalence and extent of CAC has not been compared among those with MetS, diabetes, or neither condition.
METHODS: Of 1,823 persons (36% female) age 20 to 79 years who had screening for CAC by computed tomography, 279 had MetS, 150 had diabetes, and the remainder (n = 1,394) had neither condition. Metabolic syndrome was defined with
3 of the following: body mass index
30 kg/m2; high-density lipoprotein cholesterol <40 mg/dl if male or <50 mg/dl if female; triglycerides
150 mg/dl; blood pressure
130/85 mm Hg or on treatment; or fasting glucose 110 to 125 mg/dl. The prevalence and odds of any and significant (
75th percentile) CAC among these groups and by number of MetS risk factors were determined.
RESULTS: Those with neither MetS nor diabetes, MetS, or diabetes had a prevalence of CAC of 53.5%, 58.8%, and 75.3% (p < 0.001), respectively, among men and 37.6%, 50.8%, and 52.6% (p < 0.001), respectively, among women. Coronary artery calcium increased by the number (0 to 5) of MetS risk factors (from 34.0% to 58.3%) (p < 0.001). Forty-one percent of subjects with MetS had either a >20% 10-year risk of CHD or CAC
75th percentile for age and gender. Risk factor-adjusted odds for the presence of CAC were 1.40 (95% confidence interval [CI] 1.05 to 1.87) among those with MetS and 1.67 (95% CI 1.12 to 2.50) among those with diabetes, versus those with neither condition.
CONCLUSIONS: Those with MetS or diabetes have an increased likelihood of CAC compared with those having neither condition.
| ||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
D. Sorajja, A. S. Gami, V. K. Somers, T. R. Behrenbeck, A. Garcia-Touchard, and F. Lopez-Jimenez Independent Association Between Obstructive Sleep Apnea and Subclinical Coronary Artery Disease Chest, April 1, 2008; 133(4): 927 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bertoni, N. D. Wong, S. Shea, S. Ma, K. Liu, S. Preethi, D. R. Jacobs Jr, C. Wu, M. F. Saad, and M. Szklo Insulin Resistance, Metabolic Syndrome, and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care, November 1, 2007; 30(11): 2951 - 2956. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Daly, P Hildebrandt, M Bertrand, R Ferrari, W Remme, M Simoons, K M Fox, and on behalf of the EUROPA investigators Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial Heart, November 1, 2007; 93(11): 1406 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingelsson, L. M. Sullivan, J. M. Murabito, C. S. Fox, E. J. Benjamin, J. F. Polak, J. B. Meigs, M. J. Keyes, C. J. O'Donnell, T. J. Wang, et al. Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes Diabetes, June 1, 2007; 56(6): 1718 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes Diabetes, March 1, 2007; 56(3): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MITRAKOU Women's Health and the Metabolic Syndrome Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 33 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iribarren, A. S. Go, G. Husson, S. Sidney, J. M. Fair, T. Quertermous, M. A. Hlatky, and S. P. Fortmann Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts? J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1800 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, Y. Ishizaka, H. Hashimoto, E.-I. Toda, R. Nagai, and M. Yamakado Metabolic Syndrome May Not Associate With Carotid Plaque in Subjects With Optimal, Normal, or High-Normal Blood Pressure Hypertension, September 1, 2006; 48(3): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, R. Hachamovitch, L. J. Shaw, J. D. Friedman, S. W. Hayes, L. E.J. Thomson, D. S. Fieno, G. Germano, N. D. Wong, X. Kang, et al. Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Noninvasive Risk Stratification and a Conceptual Framework for the Selection of Noninvasive Imaging Tests in Patients with Known or Suspected Coronary Artery Disease J. Nucl. Med., July 1, 2006; 47(7): 1107 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Katz, N. D. Wong, R. Kronmal, J. Takasu, D. M. Shavelle, J. L. Probstfield, A. G. Bertoni, M. J. Budoff, and K. D. O'Brien Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis Circulation, May 2, 2006; 113(17): 2113 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Shaw, C. N. Bairey Merz, C. J. Pepine, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, S. Mankad, B. L. Sharaf, et al. Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S4 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D Wong Review: Cardiovascular risk assessment in the metabolic syndrome, screening for subclinical disease, and implications for treatment The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 305 - 313. [Abstract] [PDF] |
||||
![]() |
N. D. Wong and S. Malik C-Reactive Protein for Cardiovascular Risk Assessment in the Metabolic Syndrome Diabetes Care, October 1, 2005; 28(10): 2598 - 2599. [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden Inflammation, Atherosclerosis, and Aspects of Insulin Action Diabetes Care, September 1, 2005; 28(9): 2312 - 2319. [Full Text] [PDF] |
||||
![]() |
C. J. Girman, J. M. Dekker, T. Rhodes, G. Nijpels, C. D. A. Stehouwer, L. M. Bouter, and R. J. Heine An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes: The Hoorn Study Am. J. Epidemiol., September 1, 2005; 162(5): 438 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Tzou, P. S. Douglas, S. R. Srinivasan, M. G. Bond, R. Tang, W. Chen, G. S. Berenson, and J. H. Stein Increased Subclinical Atherosclerosis in Young Adults With Metabolic Syndrome: The Bogalusa Heart Study J. Am. Coll. Cardiol., August 2, 2005; 46(3): 457 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Wong, A. Rozanski, H. Gransar, R. Miranda-Peats, X. Kang, S. Hayes, L. Shaw, J. Friedman, D. Polk, and D. S. Berman Metabolic Syndrome and Diabetes Are Associated With an Increased Likelihood of Inducible Myocardial Ischemia Among Patients With Subclinical Atherosclerosis Diabetes Care, June 1, 2005; 28(6): 1445 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, Y. Ishizaka, E.-I. Toda, R. Nagai, and M. Yamakado Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1038 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takamiya, W. R. Zaky, D. Edmundowics, T. Kadowaki, H. Ueshima, L. H. Kuller, and A. Sekikawa World Health Organization-Defined Metabolic Syndrome Is a Better Predictor of Coronary Calcium Than the Adult Treatment Panel III Criteria in American Men Aged 40-49 Years Diabetes Care, December 1, 2004; 27(12): 2977 - 2979. [Full Text] [PDF] |
||||
![]() |
S. Malik, N. D. Wong, S. S. Franklin, T. V. Kamath, G. J. L'Italien, J. R. Pio, and G. R. Williams Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults Circulation, September 7, 2004; 110(10): 1245 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman, N. D. Wong, H. Gransar, R. Miranda-Peats, J. Dahlbeck, S. W. Hayes, J. D. Friedman, X. Kang, D. Polk, R. Hachamovitch, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography J. Am. Coll. Cardiol., August 18, 2004; 44(4): 923 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Reilly, M. L. Wolfe, T. Rhodes, C. Girman, N. Mehta, and D. J. Rader Measures of Insulin Resistance Add Incremental Value to the Clinical Diagnosis of Metabolic Syndrome in Association With Coronary Atherosclerosis Circulation, August 17, 2004; 110(7): 803 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Berman and N. D. Wong Implications of estimating coronary heart disease risk in the U.S. population J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1797 - 1798. [Full Text] [PDF] |
||||
![]() |
G. Schillaci, M. Pirro, G. Vaudo, F. Gemelli, S. Marchesi, C. Porcellati, and E. Mannarino Prognostic value of the metabolic syndrome in essential hypertension J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1817 - 1822. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Raggi, L. J. Shaw, D. S. Berman, and T. Q. Callister Prognostic value of coronary artery calcium screening in subjects with and without diabetes J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1663 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Marroquin, K. E. Kip, D. E. Kelley, B. D. Johnson, L. J. Shaw, C. N. Bairey Merz, B. L. Sharaf, C. J. Pepine, G. Sopko, S. E. Reis, et al. Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women: A Report From the Women's Ischemia Syndrome Evaluation Circulation, February 17, 2004; 109(6): 714 - 721. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |